Future challenges in preparing for and responding to bioterrorism events

Emergency Medicine Clinics of North America

Volumn 20, Issue 2, 2002, Pages 501-524

  Jones, Jessica ^a   Terndrup, Thomas E ^b   Franz, David R ^c   Eitzen Jr , Edward M ^d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham Heersink School of Medicine   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; BIOTECHNOLOGY; COMMUNITY CARE; EARLY DIAGNOSIS; EPIDEMIC; HEALTH CARE; PRIORITY JOURNAL; REVIEW;

EID: 0036313916     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(01)00010-4     Document Type: Article

References (100)

1. Historical trends related to bioterrorism: An empirical analysis
2. Expression of mouse interleukin 4 by a recombinant ectromelia virus suppresses cytolytic lymphocytic responses and overcomes genetic resistance to mousepox
3. Bioethics and biologic weapons
4. Lessons from the West Nile Viral encephalitis outbreak in New York City, 1999: Implications for bioterrorism preparedness
5. Medical preparedness for a terrorist incident involving chemical and biological agents during the 1996 Atlanta Olympic games
6. Application of a geographical information system to the tracking and control of an outbreak of shigellosis
7. Public health preparedness for biological terrorism in the USA
8. Epidemiology of bioterrorism
9. An ounce of prevention is worth a pound of cure-shoring up the public health infrastructure to respond to bioterrorist attacks
10. Addressing bioterrorist threats: Where do we go from here?
11. Weapons of mass destruction events with contaminated casualties: Effective planning for health care facilities
12. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars
13. Multi-analyte interrogation using the fiber optic biosensor
14. An array immunosensor for simultaneous detection of clinical analytes
15. Toward a rapid, integrated, and fully automated DNA diagnostic assay for Chlamydia trachomatis and Neisseria gonorrhoeae
16. Microorganism identification by mass spectrometry and protein database searches
17. Real-time measurement of fluorescence spectra from single airborne biological particles
18. Design development and performance of a fieldable chemical and biological agent detector
19. A review of molecular recognition technologies for detection of biological threat agents
20. Applying lessons learned from anthrax case history to other scenarios
21. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care
22. A national laboratory network for bioterrorism: Evolution from a prototype network of laboratories performing routine surveillance
23. Mass psychogenic illness attributed to toxic exposure at a high school
24. Vaccines in civilian defense against bioterrorism
25. Immunization against potential biological warfare agents
26. Inhalational anthrax: Epidemiology, diagnosis and management
27. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax
28. The looming threat of bioterrorism
29. Addressing the potential threat of bioterrorism: Value added to an improved public health infrastructure
30. Anthrax as a biological weapon: Medical and public health management
31. Work performance at 40 degrees C with Canadian Forces biological and chemical protective clothing
32. Potential values of a simple biological warfare protective mask
33. Vaccines, pharmaceutical products and bioterrorism: Challenges for the US Food and Drug Administration
34. Disaster medical education for all physicians and physician extenders
35. When a bioweapon strikes who will be in charge?
36. Medical examiners, coroners, and bioterrorism
37. Developing objectives, content, and competencies for the training of emergency medical technicians, emergency physicians, and emergency nurses to care for casualties resulting from nuclear, biological or chemical (NBC) incidents
38. Coping with bioterrorism is difficult but may help us respond to new epidemics
39. Survey and summary: From DNA biosensor to gene chips
40. Disaster planning part II: Disaster problems, issues and challenges identified in the research literature
41. Preparing hospitals for toxicological mass casualties events
42. Mitigation emerges as major strategy for reducing losses caused by natural disasters
43. Implications of pandemic influenza for bioterrorism response
44. The Oklahoma bombing: Lessons learned
45. Development of computer-assisted patient control for use in the hospital setting during mass casualty incident
46. The Tokyo subway sarin attack: Disaster management, part 3: National and international responses
47. The Tokyo subway sarin attack: Disaster management, part 2: Hospital response
48. Domestic preparedness for events involving weapons of mass destruction
49. Aftermath of a hypothetical smallpox disaster
50. A plague on your city: Observations from TOPOFF
51. The Tokyo subway sarin attack: Disaster management, part 1: Community emergency response
52. Smallpox: An attack scenario
53. Telecommunications systems in support of disaster medicine: Applications of basic information pathways
54. Endogenous mediators in emergency department patients with presumed sepsis: Are levels associated with progression to severe sepsis and death?
55. Bacterial sepsis and septic shock: Nitric oxide in the pathogenesis of sepsis
56. Bacterial sepsis and septic shock: Clinical trials for severe sepsis. Past failures and future hopes
57. Anti-inflammatory cytokines
58. Immunologic response to infection and its role in septic shock
59. Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure
60. Using DNA microarrays to study host-microbe interactions
61. Comparing functional genomic datasets: Lessons from DNA microarray analyses of host-pathogen interactions
62. Biosensor chip mass spectrometry: A chip-based proteomics approach
63. Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax
64. Immunomodulatory therapy in the management of viral infections in patients with HIV infection
65. Immunomodulatory and pharmacologic properties of imiquimod
66. The use of granulocyte colony-stimulating factor in critically ill patients
67. Filgrastim in patients with pneumonia and severe sepsis or septic shock
68. Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998
69. Bioterrorism: Media hype or real potential nightmare?
70. The prospect of domestic bioterrorism
71. Hospital preparedness for victims of chemical or biological terrorism